How The Story Behind Marsh & McLennan Companies (MRSH) Is Shifting With Mixed Analyst Views

Simply Wall St

Thu, February 19, 2026 at 11:14 AM GMT+9 6 min read

In this article:

•                                       StockStory Top Pick 
  

  MRSH

  +1.30%

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

Marsh & McLennan’s updated fair value estimate edges to US$207.95, slightly below the prior US$208.70. This reflects a more balanced read of recent research that mixes cautious sector views with ongoing confidence in the company’s earnings quality and resilience. The small lift in the discount rate to 6.98% from 6.96% and a modestly higher long term dollar revenue growth assumption at 5.23% from 5.14% capture this tension between concerns around softer P&C pricing and continuing optimism around execution, digital demand, AI related client spending, and the Thrive initiative. Stay with us to see how you can keep on top of these kinds of targeted narrative shifts as they develop.

Stay updated as the Fair Value for Marsh & McLennan Companies shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Marsh & McLennan Companies.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

Raymond James shifted to a Strong Buy rating with a US$225 price target, framing Marsh & McLennan as an attractive risk reward name after what it calls a valuation reset. The firm supports this view with what it sees as a high quality earnings profile, consistent margin expansion, and sector leading credit metrics.

Bullish analysts point to digital infrastructure demand, AI related client spending, and productivity gains from the Thrive initiative as helping the company support organic growth and extend its track record of margin expansion, even as broader P&C pricing softens.

Barclays, with an Overweight rating and a US$210 price target, and Keefe Bruyette, with a Market Perform rating and a US$205 price target, acknowledge growth headwinds for brokers. They still see enough execution strength to justify price targets broadly in line with or above many recent sector views.

RBC Capital, at Sector Perform with a US$200 price target, cites expectations for low to mid single digit organic revenue growth and overall revenue growth in the 4% to 6% range. It ties its stance to what it sees as solid return on equity and book value per share growth across carriers and brokers.

🐻 Bearish Takeaways

BofA keeps an Underperform rating and trims its price target to US$174 from US$181, flagging concerns that P&C pricing trends for many products do not appear positive. It notes that loss costs are rising more steeply than prices in some liability lines and that personal auto rates look flattish while some investors expect declines.

Wells Fargo maintains an Equal Weight rating and lowers its price target to US$199 from US$212. It emphasizes that into results it is focused on pricing, loss trends, and reserves for P&C carriers and on organic growth and margins for brokers, which it implies could face pressure.

Goldman Sachs, at Neutral with a price target lifted to US$199 from US$196, reiterates its view that the P&C cycle is in a softening phase. It points to increased capital supply and competition that it believes could lead to slower growth, pricing, and margins than the Street generally expects.

RBC Capital, while not outright bearish, also highlights emerging earnings headwinds including a softening P&C cycle, difficult catastrophe comparisons, and reserving uncertainty. It also points to a particularly soft start to 2026 for the sector, which it links to down pricing at reinsurance renewals.

 






La historia continúa  

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives!

NYSE:MRSH 1-Year Stock Price Chart

What’s in the News

The board has authorized a new share repurchase program allowing Marsh & McLennan Companies to buy back up to US$6b of its shares, following board approval of the plan on November 20, 2025.

The company reports on its ongoing buyback activity, stating that from October 1, 2025 to November 20, 2025 it repurchased 5,485,681 shares for US$1,000m, and that since the program announced in 2010 it has repurchased 154,243,892 shares for US$13,445.25m.

Management indicates plans to deploy about US$5b of capital in 2026 across dividends, acquisitions, and share repurchases, with the mix depending on how the M&A pipeline develops.

Marsh McLennan Agency has launched Secure Harbor, a group captive insurer tailored to skilled nursing, assisted living, and senior living communities, offering general and professional liability coverage and access to MMA's third party claims administration and safety consulting teams. The company also plans to change its New York Stock Exchange ticker symbol to MRSH from MMC effective January 14, 2026, alongside amended and restated bylaws that include clarifications and updates from the same date.

How This Changes the Fair Value For Marsh & McLennan Companies

Fair Value: The updated fair value estimate edges down slightly to US$207.95 from US$208.70.

Discount Rate: The discount rate moves up marginally to 6.98% from 6.96%, which points to a slightly higher required return in the model.

Revenue Growth: The assumed long term dollar revenue growth rate increases modestly to 5.23% from 5.14%.

Net Profit Margin: The modeled net profit margin ticks higher to 18.36% from 17.82%.

Future P/E: The assumed future P/E multiple steps down to 20.25x from 21.34x. This indicates a slightly lower valuation multiple applied to forward earnings.

🔔 Never Miss an Update: Follow The Narrative

Narratives on Simply Wall St let you connect a company’s story to the numbers. You set out your view on Marsh & McLennan, link it to forecasts for revenue, earnings, and margins, then see what that implies for fair value versus today’s share price. Because Narratives live inside the Community page and update when fresh news or earnings land, they give you a clear, evolving framework to think about when to buy or sell.

If you want the full context behind the latest fair value update, it is worth reading the original Marsh & McLennan Narrative on Simply Wall St.

How growing global risk complexity, regulation, and expanding insurance demand tie into analysts' revenue and earnings expectations for Marsh & McLennan.

Why digital investments and acquisitions are built into assumptions for margins, future P/E, and long term earnings power.

What could challenge this view, from a soft P&C cycle and consulting demand swings to acquisition integration risk and tech driven competition.

Head over to the Simply Wall St Community and follow the Narrative on Marsh & McLennan Companies to stay on top of how the story, forecast, and fair value move together. You can find it here: MRSH: Earnings Should Stay Resilient As Soft P And C Cycle Persists. Curious how numbers become stories that shape markets? Explore Community Narratives

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include MRSH.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Condiciones y Política de privacidad

Privacy Dashboard

More Info